Clinical Trials

NCT IdNCT04107103
TitleNivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma
ConditionSCCHN
StudyTypeInterventional
OrganizationAHS Cancer Control Alberta
Sponsor/CollaboratorsAHS Cancer Control Alberta
StatusRecruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
  • Cross Cancer Institute, Edmonton, Canada
DescriptionThe purpose of this study is to find out what effects the combination of Nivolumab and Pemetrexed has on you and your cancer. The safety of this combination and the effectiveness of this treatment will be studied.